DIE ONKOGENE MUTATIONSLANDSCHAFT EINSCHRÄNKENDER MHC-1-GENOTYP
European patent · EP3645028 · In force
Register entry
- Publication number
- EP3645028
- Application number
- EP18823785
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 26, 2018
- Published
- May 6, 2020
- Granted
- Jul 9, 2025
- Protection ends at the latest
- Jun 25, 2038
- Next annual fee due
- Jun 30, 2026
- IPC classes
- G16B 20/20 (2019.01)C07K 14/74 (2006.01)C12Q 1/6883 (2018.01)C12Q 1/6886 (2018.01)G01N 33/564 (2006.01)G01N 33/574 (2006.01)G01N 33/569 (2006.01)
- Priority
- US 201762525539 P 27.06.2017
- PCT application
- PCT/US2018/039455 26.06.2018
- PCT publication
- WO2019/005764 03.01.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 21, 2026
Change
Published in Swissreg on 21.05.2026
- Jul 9, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 09.07.2025
Parties
Holder
Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
333 Cottman Avenue, Philadelphia, PA 19111-2497, US
Universitat Pompeu Fabra
Universitat Pompeu-Fabra
Ed. Merce Rodoreda C/ Ramon Trias Fargas, 25-27, 08005 Barcelona, ES
The Regents of the University of California
1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200, US
Inventor
FONT-BURGADA, Joan
Philadelphia, PA 19111-2497, US
ROSSELL, David
08005 Barcelona, ES
CARTER, Hannah, K.
Oakland, CA 94607-5200, US
MARTY, Rachel
Oakland, CA 94607-5200, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.